Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CSBR Champions Oncology, Inc.
$6.48 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CSBR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 91.0M
Enterprise value 87.9M
Trailing PE 38.52941
Forward PE 65.5
PEG Ratio -0.64215683333333
Enterprise to EBITDA 22.144
Enterprise to revenue 1.505
Price to book MRQ 21.833334
Price to sales TTM 1.5568163

Financials

Fiscal Year Ends 2025-04-30
Most Recent Quarter (MRQ) 2025-10-31
Revenue (TTM) 58.4M
EBITDA 6.8M
Diluted EPS TTM 0.17
Total Cash (MRQ) 8.5M
Current ratio (MRQ) 0.963
Operating Cash Flow (TTM) 6.2M

CSBR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CSBR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.